企業を読み込み中
Just reported
Q3 2026 results
From Chemed's results release of 2026年10月27日; its quarterly report has since been filed.
Revenue
Actual
$690.9M
+11% y/y
+2.6% q/qGuided
—
No guide given
EPS, GAAP
Actual
$5.45
+22% y/y
+6.2% q/qGuided
—
No guide given
Operating income, GAAP
Actual
$96.4M
+29% y/y
+8.1% q/qGuided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Keep exploring
The themes Chemed is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
The themes it is part of
Highest-graded in Medical Care Facilities
Graded A or B and worth $2B or more: A first, then the largest.
THCTenet Healthcare Corp.$23.3BA+
EHCEncompass Health Corporation$14BA+
ENSGEnsign Group, Inc.$10.9BA
PACSPACS Group, Inc.$7.9BA
CONConcentra Group Holdings Parent, Inc.$5.5BA
Grade rose recently in Healthcare
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
DHRDanaher Corporation2026年10月21日CBGraded C, now B
MCKMckesson Corporation2026年11月4日BAGraded B, now A
CVSCVS Health Corp2026年11月4日BAGraded B, now A
EWEdwards Lifesciences Corporation2026年11月4日BAGraded B, now A
BIIBBiogen Inc.2026年10月28日BAGraded B, now A
Chemed Corp. 自身が米国証券取引委員会（SEC）に提出した書類にもとづきます。数字は報告されたままで、1 株当たりの履歴は今日の株数基準に修正済みです。 これは事業の説明です——投資助言ではなく、売買を勧めるものでもありません。
